←
AAS626 posts
AAS avatar

AAS

@atheroaussie

The Australian Atherosclerosis Society (AAS) promotes, at a national level, the advancement of science, research and teaching in the field of atherosclerosis

◷ Joined January 2012▧ 282 Photos and videos
AAS avatar
AAS@atheroaussie·Mar 9

We are delighted to be partnering with the #IMMA conference. If you're considering joining the conference register now. The early bird price is live and plenty of oral presentation slots are on offer. For more information: bit.ly/4twsl2Z

Post attachment
AAS avatar
AAS@atheroaussie·23 Sep 2025

Join us to her about some cutting-edge research at the joint virtual seminar, delivered by Dr Jonathan Noonan from the Baker Heart and Diabetes Institute

Post attachment
AAS avatar
AAS@atheroaussie·10 Jun 2025

The June AAS, AVBS, ANZMS joint virtual seminar will be held today- hope to see you there!

Post attachment
AAS avatar
AAS@atheroaussie·7 Dec 2024

We are delighted to have @ChrisBursill representing Australia and the Asia Pacific on the IAS board!

The Council of Constituents Societies met on December 6 to vote on a new board of directors for the 2025-2027 term. The International Atherosclerosis Society is proud to announce its new board, effective January 1: 𝗣𝗿𝗲𝘀𝗶𝗱𝗲𝗻𝘁: Dirk Blom, MBChB, MMed - South Africa 𝗣𝗿𝗲𝘀𝗶𝗱𝗲𝗻𝘁-𝗘𝗹𝗲𝗰𝘁: Samia Mora, MD, MHS - United States 𝗦𝗲𝗰𝗿𝗲𝘁𝗮𝗿𝘆: Viviane Zorzanelli Rocha Giraldez, MD - Brazil 𝗧𝗿𝗲𝗮𝘀𝘂𝗿𝗲𝗿: Jessica Peña, MD, MPH - United States 𝗜𝗺𝗺𝗲𝗱𝗶𝗮𝘁𝗲 𝗣𝗮𝘀𝘁 𝗣𝗿𝗲𝘀𝗶𝗱𝗲𝗻𝘁: Peter Libby, MD - United States 𝗘𝗹𝗲𝗰𝘁𝗲𝗱 𝗠𝗲𝗺𝗯𝗲𝗿𝘀 𝗮𝘁 𝗟𝗮𝗿𝗴𝗲: Mutaz Al-Khnifsawi, MD - Iraq Fahad Alnouri, MD, MSc - Saudi Arabia (@AlnouriDr) Christina Bursill, PhD - Australia Ioanna Gouni-Berthold, MD - Germany Jianjun Li, MD, PhD - China Maxima Mendez Castillo, MD - Dominican Republic Manfredi Rizzo, MD, PhD - Italy Banshi Saboo, MBBS, MD - India Shizuya Yamashita, MD, PhD - Japan Congrats to the newly elected board! Let's keep working together toward better prevention and care of atherosclerosis. #ISA2024 #CollaborateForImpact

Post attachment
AAS avatar
AAS@atheroaussie·6 Dec 2024

Former AAS President and long time member, @ChrisBursill delivered an excellent talk about the protective role of NRF2 activation in reducing plaque burden and instability #ISA2024

Post attachment
AAS avatar
AAS@atheroaussie·5 Dec 2024

Our long standing AAS board member, Prof Gerald Watts, presented late-breaking data showing results of the PALISADE trial which identifies a new apoC3 inhibitor-based treatment to lower triglycerides and reduce pancreatitis in patients with FCS. Published in NEJM #ISA2024

Post attachment